We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$175M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$26.7M
3
SOXX icon
iShares Semiconductor ETF
SOXX
+$12.1M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$11.3M
5
IWV icon
iShares Russell 3000 ETF
IWV
+$9.58M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AEI icon
4426
Alset
AEI
$41.6M
$9K ﹤0.01%
75
+14
+23% +$1.96K
BCML icon
4427
BayCom
BCML
$332M
$9K ﹤0.01%
496
-628
-56% -$11.4K
CQP icon
4428
Cheniere Energy
CQP
$32.6B
$9K ﹤0.01%
206
– –
DBE icon
4429
Invesco DB Energy Fund
DBE
$90.4M
$9K ﹤0.01%
582
-685
-54% -$9.89K
DBX icon
4430
Dropbox
DBX
$8.07B
$9K ﹤0.01%
298
-1,513
-84% -$41.3K
DSL
4431
DoubleLine Income Solutions Fund
DSL
$1.23B
$9K ﹤0.01%
+500
New +$9.07K
EOSE icon
4432
Eos Energy Enterprises
EOSE
$1.47B
$9K ﹤0.01%
+507
New +$8.17K
HYPD
4433
Hyperion DeFi Inc
HYPD
$39.6M
$9K ﹤0.01%
24
-6
-20% -$2.47K
GLUE icon
4434
Monte Rosa Therapeutics
GLUE
$1.35B
$9K ﹤0.01%
+400
New +$8.15K
HLMN icon
4435
Hillman Solutions
HLMN
$1.77B
$9K ﹤0.01%
716
-129
-15% -$1.44K
IGA
4436
Voya Global Advantage and Premium Opportunity Fund
IGA
$158M
$9K ﹤0.01%
+956
New +$9.2K
IGLB icon
4437
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.78B
$9K ﹤0.01%
133
-700
-84% -$47.6K
MBRX icon
4438
Moleculin Biotech
MBRX
$3.06M
$9K ﹤0.01%
+7
New +$9.55K
MFIN icon
4439
Medallion Financial
MFIN
$249M
$9K ﹤0.01%
1,111
+597
+116% +$5.15K
MGYR icon
4440
Magyar Bancorp
MGYR
$123M
$9K ﹤0.01%
784
-71
-8% -$786
MIST icon
4441
Milestone Pharmaceuticals
MIST
$157M
$9K ﹤0.01%
+1,566
New +$8.88K
NVGS icon
4442
Navigator Holdings
NVGS
$1.25B
$9K ﹤0.01%
783
-2,726
-78% -$28.8K
OIS icon
4443
Oil States International
OIS
$534M
$9K ﹤0.01%
1,134
-5,017
-82% -$33.6K
PLX icon
4444
Protalix BioTherapeutics
PLX
$200M
$9K ﹤0.01%
4,658
+3,570
+328% +$12.3K
PROF
4445
Profound Medical
PROF
$267M
$9K ﹤0.01%
530
+473
+830% +$8.8K
PRPH
4446
DELISTED
ProPhase Labs
PRPH
$9K ﹤0.01%
147
-91
-38% -$5.11K
PW
4447
Power REIT
PW
$2.99M
$9K ﹤0.01%
22
+7
+47% +$3K
QLD icon
4448
ProShares Ultra QQQ
QLD
$14B
$9K ﹤0.01%
+252
New +$8.16K
RZLT icon
4449
Rezolute
RZLT
$451M
$9K ﹤0.01%
647
-1,964
-75% -$17.7K
SIF icon
4450
SIFCO Industries
SIF
$136M
$9K ﹤0.01%
889
+787
+772% +$9.27K
176 177
178
179 180

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.